Rare event detection using mass tags
US-2016086781-A1 · Mar 24, 2016 · US
US11061035B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11061035-B2 |
| Application number | US-201716071347-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 20, 2017 |
| Priority date | Jan 22, 2016 |
| Publication date | Jul 13, 2021 |
| Grant date | Jul 13, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention generally relates to charged mass label compositions and methods of use thereof for detecting a target analyte in a sample. In certain aspects, the invention provides a charged mass label composition including an affinity reagent, and a mass label precursor bound to the affinity reagent. The mass label precursor includes a label binding unit and a mass label. The label binding unit reversibly binds the mass label to the affinity reagent. The mass label includes a charge unit and a mass label unit having a pre-defined mass-to-charge-value in a mass spectrum.
Opening claim text (preview).
What is claimed is: 1. A charged mass label composition comprising: an affinity reagent; and a mass label precursor bound to the affinity reagent, wherein the mass label precursor comprises a label binding unit and a mass label, the label binding unit reversibly binding the mass label to the affinity reagent, wherein the mass label comprises a charge unit covalently coupled to a mass label unit through a fragmentation resistant covalent bond wherein the charge unit is capable of being released from the mass label upon ionization, wherein the mass label unit is neutral and has a pre-defined mass-to-charge-value in a mass spectrum, and wherein upon ionization, the charge unit releases from the mass label unit and the mass label unit is detectable in the mass spectrum due to the mass label unit having the pre-defined mass-to-charge-value in a mass spectrum; wherein the charge unit comprises one or more chemical moieties selected from the group consisting of formulas wherein at least one X is a quaternary ammonium cation or a quaternary phosphonium cation that is optionally substituted by at least one R selected from the group consisting of hydrogen, alkyl, and an aromatic organic derivative. 2. The charged mass label composition according to claim 1 , wherein the affinity reagent comprises at least one member of a specific binding pair. 3. The charged mass label composition according to claim 1 , wherein the charge unit is a chemical moiety selected from the group consisting of: carnitine, imidazolium, pyridinium, tetra ethyl amine, benzalkonium amine, alkyl benzethonium amine, triphenyl phosphonium cation, and trialkyl(2,3-dihydroxypropyl). 4. The charged mass label composition according to claim 1 , wherein the mass label unit comprises an arrangement of chemical moieties that produce one or more fragments upon ionization, wherein at least one of the one or more fragments has the pre-defined mass-to-charge-value in a mass spectrum. 5. The charged mass label composition according to claim 4 , wherein the pre-defined mass-to-charge-value in the mass spectrum of the mass label or one or more fragments of the mass label is different from background mass-to-charge-values in the mass spectrum. 6. The charged mass label composition according to claim 1 , wherein the label binding unit comprises a reversible bond. 7. The charged mass label composition according to claim 6 , wherein the reversible bond comprises an acetal or ketal bond.
for cancer · CPC title
involving oncogenic proteins · CPC title
Labels used in chemical analysis of biological material · CPC title
involving labelled substances (G01N33/53 takes precedence) · CPC title
Production of immunochemical test materials · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.